First Clinical Experience of Trevena's lead CNS Biased Ligand, TRV130, Published in Journal of Clinical Pharmacology Oct 15, 2013 8:00am EDT
Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer Sep 17, 2013 1:18pm EDT
Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study Jul 30, 2013 7:00am EDT
Journal of Clinical Pharmacology Publishes First Clinical Experience with Trevena's Heart Failure Biased Ligand TRV027 Jul 08, 2013 7:00am EDT
Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure May 09, 2013 6:00am EDT
Trevena to Present First-in-Man Study Results for Mu-Opioid Biased Ligand TRV130 Mar 18, 2013 9:00am EDT